RecruitingNot ApplicableNCT06567886

Fibromyalgia Sleep A to ZZZ Study

At Home Morning Bright Light Treatment for Chronic Nociplastic Pain


Sponsor

University of Michigan

Enrollment

390 participants

Start Date

Sep 27, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This research study is testing whether changes in sleep timing and morning light therapy may have an impact on symptoms related to fibromyalgia.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Meets 2016 revised diagnostic criteria for fibromyalgia (FM)
  • Has access to video conferencing (including web cameras and audio) and a private space for the remote study visits.

Exclusion Criteria7

  • Significant chronic disease
  • Severe hearing or memory problems
  • Pending medical leave applications at workplace
  • Current pregnancy, breastfeeding, or actively trying to get pregnant
  • Night work or travel outside the eastern time zone within 1 month of the study
  • Other research participation
  • Frequent number of special events during study period (weddings, concerts, exams, etc).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELight Therapy

Participants will self-administer the daily light therapy within a few minutes of their assigned wake up time for one hour. Researchers will provide a light log to note light on/off times, any interruptions to light therapy, and primary activity during light therapy.

BEHAVIORALSleep Stabilization

All participants will be asked to follow a fixed sleep schedule.


Locations(1)

University of Michigan

Ann Arbor, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06567886


Related Trials